219909-53-2

Basic information

• Product Name: (+/-)-2,6-dichloro-α-[4-chloro-3-(trifluoromethyl)phenyl]-4-nitrobenzene-acetonitrile
• Synonyms: (+/-)-2,6-dichloro-α-[4-chloro-3-(trifluoromethyl)phenyl]-4-nitrobenzene-acetonitrile
• CAS NO: 219909-53-2
• Molecular Weight: 409.579
• Mol File: 219909-53-2.mol

Chemical Properties

• CAS DataBase Reference: (+/-)-2,6-dichloro-α-[4-chloro-3-(trifluoromethyl)phenyl]-4-nitrobenzene-acetonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-2,6-dichloro-α-[4-chloro-3-(trifluoromethyl)phenyl]-4-nitrobenzene-acetonitrile(219909-53-2)
• EPA Substance Registry System: (+/-)-2,6-dichloro-α-[4-chloro-3-(trifluoromethyl)phenyl]-4-nitrobenzene-acetonitrile(219909-53-2)

Safety Data

• Hazardous Substances Data: 219909-53-2(Hazardous Substances Data)

Upstream product

• 22902-82-5 2-(4-chloro-3-(trifluoromethyl)phenyl)acetonitrile 
• 20098-48-0 3,4,5-trichloronitrobenzen 
• 56-37-1 N-benzyl-N,N,N-triethylammonium chloride 

Relevant articles and documents

6-azauracil derivatives as IL-5 inhibitors

The present invention is concerned with the use of compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein p represents 0, 1, 2 or 3; q represents 0, 1, 2, 3 or 4; R1

Novel IL-5 inhibiting 6-azauracil derivatives

The present invention is concerned with the compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, p and q are 0, 1, 2, 3 or 4 and q is also 5; X is O, S, NR3 or a dire